POSSIBILITIES OF PREDICTING AND PREVENTING COMPLICATIONS IN COMBINED IMPAIRMENTS IN THE COAGULANT AND ANTICOAGULANT COMPONENTS OF THE HEMOSTATIC SYSTEM IN OBSTETRIC PRACTICE


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

In clinical practice one has to encounter the situations when different congenital hemostatic defects threatened by hemorrhages are concurrent with one or another of the congenital or acquired predictors of thrombophilia. The paper describes a clinical case of the course of pregnancy, labor, or postpartum in women with combined congenital hemostatic disease and a history of late postpartum hemorrhage. The non-pregnant women showed a decrease in the level of factor XII to 20% (normal range, 75—125%) and factor IX to 50% (normal range, 75—125%) and an increase of factor VII to 145% (normal range, 75—125%). During pregnancy, there were adaptive changes in the hemostatic system: the level of factor XII increased up to 50% (normal range, 100—200%), factor IX up to 95% (normal range, 100—150%), and factor VII up to 190% (normal range, 150—250%). The total recordings of hemostasiograms corresponded to the normal gestational values during pregnancy. Fresh frozen plasma was intravenously injected in a volume of 500 ml in the first stage of labor to prevent postpartum hemorrhage. Blood loss during childbirth was 350 ml. The postpartum period was uncomplicated as long as 16 days. The hemostasiogram recordings over time were consistent with insignificant hypocoagulation with no signs of thrombinemia and hyperfibrinolysis.

全文:

受限制的访问

作者简介

P. KIRYUSHCHENKOV

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: masha-kirmail@mail.ru

M. KOVALEV

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: kovalefT@yandex.ru

M. TAMBOVTSEVA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: tambovtsevamr@mail.ru

参考

  1. Кузник Б.И., Михайлов С.В., Альфонсов А.И. Тромбогеморрагический синдром в онкогинекологии. Томск: Изд-во Томского университета; 1983: 100—11.
  2. Bonnar J., Dali Leisa, Shepard B.L. Changes in fibrinolytic system during pregnancy. Seminars Thromb. Hemost. 1990; 16(3): 221—9.
  3. Ozero M.C. Surgery in patients with hemophilia: Is thromboprophylaxis mandatory? Thromb. Res. 2012; 130(Suppl. 1): S23.
  4. Сидельникова В.М., Кирющенков П.А. Гемостаз и беременность. М.: Триада-Х; 2004: 43—7.
  5. Dargaud Y., Meunier S., Negrier C. Haemophilia and thrombophilia: an unexpected association! Haemophilia. 2004; 10(4): 319—26.
  6. Hermans C., Altisent C., Batorova A., Chambost H., De Moerloose P., Karafoulidou A. et al. Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations. Haemophilia. 2009; 15(3): 639—58.
  7. Furie B., Furie B.C. Formation of the clot. Thromb. Res. 2012; 130( Suppl. 1): S44.
  8. Макацария А.Д., ред. Тромбогеморрагические осложнения в акушерско-гинекологической практике. М.: МИА; 2011: 150-86; 894—915.
  9. Дементьева И.И., Чарная М.А., Морозов Ю.А. Патология системы гемостаза: Руководство для врачей. М.: ГЭОТАР-Медиа; 2011: 184—7.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2013
##common.cookie##